Odulimomab

Odulimomab
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Odulimomab".

content

Odulimomab^?
Therapeutic monoclonal antibody
Source	Mouse
Target	LFA-1
Identifiers
CAS number	159445-64-4
ATC code	?
PubChem	?
Chemical data
Formula	?
Mol. mass	?
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

The introduction to this article provides insufficient context for those unfamiliar with the subject.
Please help improve the article with a good introductory style.

Odulimomab is a mouse monoclonal antibody which is used as an immunosuppressive drug.

This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.

v • d • e

Immunomodulators – Immunosuppressants – Immunosuppressive drugs (L04)

Intracellular
(signal initiation)

Antimetabolites	purine synthesis inhibitor: Azathioprine · Mycophenolic acid pyrimidine synthesis inhibitor: Leflunomide · Teriflunomide antifolate: Methotrexate

Macrolides/ other IL-2 inhibitors	FKBP/Cyclophilin/Calcineurin: Tacrolimus · Ciclosporin · Pimecrolimus Abetimus · Gusperimus

TNF-α inhibitor	Thalidomide

Extracellular

Antibodies

Monoclonal

Serum target (noncellular)	Complement component 5 (Eculizumab) · TNFs (Infliximab, Adalimumab, Certolizumab pegol, Afelimomab, Golimumab, Nerelimomab) · Interleukin 5 (Mepolizumab) · Immunoglobulin E (Omalizumab) Interferon (Faralimomab) IL-6 (Elsilimomab) IL-12 and IL-13 (Ustekinumab)

Cellular target	CD3 (Muromonab-CD3, Otelixizumab, Teplizumab, Visilizumab) · CD4 (Clenoliximab, Keliximab, Zanolimumab) · CD11a (Efalizumab) · CD18 (Erlizumab) · CD20 (Ocrelizumab, Pascolizumab) · CD23 (Lumiliximab) · CD40 (Teneliximab, Toralizumab) · CD62L/L-selectin (Aselizumab) · CD80 (Galiximab) · CD147/Basigin (Gavilimomab, Ziralimumab) · CD154 (Ruplizumab) BLyS (Belimumab) · CTLA-4 (Ipilimumab, Tremelimumab) · CAT (Bertilimumab, Lerdelimumab, Metelimumab) · Integrin (Natalizumab) · Interleukin-6 receptor (Tocilizumab) · LFA-1 (Odulimomab) IL-2 receptor/CD25 (Basiliximab, Daclizumab, Inolimomab) T-lymphocyte (Zolimomab aritox)

Unsorted	Atlizumab, Atorolimumab, Cedelizumab, Dorlimomab aritox, Dorlixizumab, Fontolizumab, Gantenerumab, Gomiliximab, Lebrilizumab, Maslimomab, Morolimumab, Pexelizumab, Reslizumab, Rovelizumab, Siplizumab, Talizumab, Telimomab aritox, Vapaliximab, Vepalimomab

Polyclonal

Anti-thymocyte globulin · Anti-lymphocyte globulin

-cept (Fusion protein)

CTLA-4 (Abatacept, Belatacept) · Aflibercept · Alefacept · Rilonacept · TNF inhibitor (Etanercept)

Intracellular
(signal reception)

IL-1 receptor antagonists	Anakinra

mTOR	Sirolimus · Deforolimus · Everolimus · Temsirolimus · Zotarolimus

v • d • e Mouse monoclonal antibodies ("-o-")

"-govo-" (ovarian tumor)	Abagovomab, Igovomab, Oregovomab

"-limo-" (immune system)	Afelimomab, Dorlimomab aritox, Elsilimomab, Enlimomab pegol, Faralimomab, Gavilimomab, Inolimomab, Maslimomab, Nerelimomab, Odulimomab, Telimomab aritox, Vepalimomab, Zolimomab aritox

"-tumo-" (miscellaneous tumor)	Altumomab, Anatumomab mafenatox, Arcitumomab, Bectumomab, Blinatumomab, Detumomab, Epitumomab cituxetan, Ibritumomab tiuxetan, Minretumomab, Mitumomab, Naptumomab estafenatox, Nofetumomab merpentan, Pemtumomab, Pintumomab, Satumomab pendetide, Taplitumomab paptox, Tenatumomab, Tositumomab, 3F8

"-leso-" (infectious lesions)	Besilesomab, Fanolesomab^§, Lemalesomab, Sulesomab

"-ciro-" (cardiovascular)	Biciromab brallobarbital, Imciromab

"-pro-" (prostate tumor)	Capromab pendetide

"-baco-" (bacterial)	Edobacomab

"-colo-" (colonic tumor)	Edrecolomab, Nacolomab tafenatox

^§Withdrawn

Your Ad Here